ClinicalTrialsFinder

NMO Spectrum Disorder Clinical Trials in Xi’an, Shanxi

1 recruitingXi’an, Shanxi, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)

NMO Spectrum Disorder
Shanghai Pharmaceuticals Holding Co., Ltd45 enrolled4 locationsNCT05145361